![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1316, 2001-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Budesonide improves QOL in Crohn's disease
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IL-10: treatment option for Crohn's disease?
Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vercirnon for the treatment of Crohn's disease
By Arseneau Kristen O Cominelli Fabio
Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. :